| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | France | 2 | |
| #4 | Australia | 1 | |
| #5 | Canada | 1 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Microorganisms | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Desallais Lucille | 13 |
| #2 | Zagury Jean-Francois | 7 |
| #3 | Zagury Jean-François | 7 |
| #4 | Salles Jean-Pierre | 6 |
| #5 | Montes Matthieu | 5 |
| #6 | Ratsimandresy Rojo | 1 |
| Publication | Filing date | Title |
|---|---|---|
| FR3078535A1 | ANTI-PD-L1 VACCINE COMPOSITION | |
| FR3078536A1 | ANTI-PD-1 VACCINE COMPOSITION | |
| WO2017118491A1 | Method for treatment of self-protein-related diseases | |
| CA2843665A1 | Anti-il-6 vaccine composition | |
| EP2480251A1 | Carrier conjugates of il-23-peptides and their induced antibodies |